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Abstract
Mowat-Wilson syndrome (MWS) is a multiple congenital anomaly syndrome characterized by a
distinct facial phenotype (high forehead, frontal bossing, large eyebrows, medially flaring and sparse
in the middle part, hypertelorism, deep set but large eyes, large and uplifted ear lobes, with a central
depression, saddle nose with prominent rounded nasal tip, prominent columella, open mouth, with
M-shaped upper lip, frequent smiling, and a prominent but narrow and triangular pointed chin),
moderate-to-severe intellectual deficiency, epilepsy and variable congenital malformations including
Hirschsprung disease (HSCR), genitourinary anomalies (in particular hypospadias in males),
congenital heart defects, agenesis of the corpus callosum and eye anomalies. The prevalence of
MWS is currently unknown, but 171 patients have been reported so far. It seems probable that
MWS is under-diagnosed, particularly in patients without HSCR. MWS is caused by heterozygous
mutations or deletions in the Zinc finger E-box-binding homeobox 2 gene, ZEB2, previously called
ZFHX1B (SIP1). To date, over 100 deletions/mutations have been reported in patients with a typical
phenotype; they are frequently whole gene deletions or truncating mutations, suggesting that
haploinsufficiency is the main pathological mechanism. Studies of genotype-phenotype analysis
show that facial gestalt and delayed psychomotor development are constant clinical features, while
the frequent and severe congenital malformations are variable. In a small number of patients,
unusual mutations can lead to an atypical phenotype. The facial phenotype is particularly important
for the initial clinical diagnosis and provides the hallmark warranting ZEB2 mutational analysis, even
in the absence of HSCR. The majority of MWS cases reported so far were sporadic, therefore the
recurrence risk is low. Nevertheless, rare cases of sibling recurrence have been observed.
Congenital malformations and seizures require precocious clinical investigation with intervention
of several specialists (including neonatologists and pediatricians). Psychomotor development is
delayed in all patients, therefore rehabilitation (physical therapy, psychomotor and speech therapy)
should be started as soon as possible.
Disease name
Mowat-Wilson syndrome
Definition
Mowat-Wilson syndrome (MWS; MIM# 235730) is a
genetic disease caused by heterozygous mutations or dele-
tions of the ZEB2 gene, and characterized by typical face,
moderate-to-severe mental retardation, epilepsy and vari-
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disease (HSCR), genital anomalies (particularly hypospa-
dias in males), congenital heart disease (CHD), agenesis
of the corpus callosum (ACC) and eye defects. The clinical
aspects of the syndrome were first described by Mowat et
al in 1998, who also identified a locus at chromosome
2q21-q23 [1]. In 2001, two groups independently discov-
ered the cause of MWS as mutation or deletion of the
ZEB2 gene (MIM# 605802) from studies of two de novo
translocations and demonstrated intragenic truncating
mutations in several other individuals affected by the dis-
ease [2,3].
Epidemiology
The prevalence of MWS is currently unknown, but it
seems probable that the syndrome is under-diagnosed,
particularly in patients without HSCR [4]. Since the first
delineation by Mowat et al (1998), approximately 171
patients with ZEB2 mutations, deletions or cytogenetic
abnormalities have been reported primarily from North-
ern Europe, Australia, Italy and the United States, and over
100 mutations have been described [2-31]. The male/
female ratio is approximately 1,42:1 [19,22,24,29-31].
The syndrome has been identified in several ethnic groups
[22], with similar clinical features in all populations.
Clinical description
Clinical manifestations of the MWS are presented in Table
1.
Facial gestalt
The clinical features of the face are very typical and the
diagnosis of MWS is based on recognition of the distinc-
tive facial gestalt, usually associated with severe mental
retardation. This phenotype, which changes with age, typ-
ically prompts the clinician to consider the diagnosis (Fig-
ures 1, 2, 3).
In infancy, there are excess nuchal skin, a rounded skull
shape, a sparse fine hair and a puffy anterior neck; the face
is square shaped with high forehead, frontal bossing,
hypertelorism, strabismus, epicanthus, deep set but large
eyes, a broad nasal bridge, saddle nose with prominent
rounded nasal tip, prominent columella, open mouth,
with M-shaped upper lip, frequent smiling, and a promi-
nent but narrow and triangular pointed chin. Additional
suggestive facial features include telecanthus, a full or
everted lower lip and posteriorly rotated ears. The more
consistent and easily recognisable features are the eye-
brows, which are large, medially flaring and sparse in the
middle part and the ear lobes, which are very typical (Fig-
ures 4, 5). They are large and uplifted with a central
depression and have been described as being like "orec-
chiette pasta" or like "red blood corpuscles" in shape.
The facial phenotype of MWS is quite distinct and changes
with age: in older children the eyebrows become heavier,
broad and horizontal, with an increased wide middle sep-
aration and medial sparseness [10,19,22]. The nasal tip
lengthens and becomes more depressed, the columella is
more prominent, leading to the appearance of a short
philtrum, the nasal profile becomes convex, the face tends
to elongate and the jaw is more pronounced.
In adolescents, the nasal tip overhangs the philtrum, the
face becomes long with prognathism, and a long, pointed
or "chisel-shaped" chin [10,19,22]. The uplifted ear lobes
do not change significantly with time (with the exception
of the central depression, which is less obvious in adults)
and are an excellent diagnostic clue.
Growth
At birth, growth parameters are usually in the normal
range, including head circumference. The mean birth
weight at term is 3370 g (25th–50thcentile), the mean
length is 50.9 cm (50th–75th centile) and the mean head
circumference is 33 cm (3rd–10th centile). The cranial cir-
cumference at birth is, in general, one centile less than
that of weight and length [12]. Microcephaly is sometimes
present at birth, but more often develops gradually in
infancy and not all children are microcephalic (at or
below 2SD below the mean). Microcephaly is a common
but not constant feature and was present in 135 out of 166
of the published cases describing this clinical sign (81%)
Table 1: Mowat-Wilson Syndrome: Clinical features in patients 
with ZEB2 mutations [1-31].
Clinical features Published cases (n = 171)
Facial gestalt 166/170 (97%)
M:F 100:70
Mental retardation all, moderate, usually severe
Microcephaly 135/166 (81%)
Seizures 102/139 (73%)
HSCR 97/170 (57%)
Constipation 19/73 (26%)
CHD 87/167 (52%)
Urogenital/renal anomalies 81/156 (51%)
Hypospadias 33/63 (52%)
Cryptorchidism 23/63 (36%)
Renal anomalies 20/156 (12.8%)
Short stature 34/73 (46%)
Hypoplasia or agenesis of corpus 
callosum
67/155 (43%)
Pyloric stenosis 8/170 (4.7%)
Structural eye anomalies 7/170 (4.1%)
Cleft palate 5/170 (2,9%)
Pulmonary artery sling with/without 
tracheal stenosis/hypoplasia
5/167 (2.9%)
ZEB2 mutations AllPage 2 of 12
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cumference was often between the 3rd and the 10th centile.
Most patients are of slender build. Postnatal short stature
is usual (34 out of 73 of the published cases with available
Mowat-Wilson Syndrome, clinical features of Patient 2 at age: (A) 1 year and 6 months; (B-C) 3 y rs and 5 months; (D-E) 8 years nd 1 monthFigu e 2
Mowat-Wilson Syndrome, clinical features of Patient 2 at age: 
(A) 1 year and 6 months; (B-C) 3 years and 5 months; (D-E) 
8 years and 1 month.
Mowat-Wilson Syndrome, clinical features of Patient 1 at age: (A) 1 year and 6 months; (B-C) 5 y rs; (D-E) 13 years and 8m nths; (F-G) 18 yearsFigure 1
Mowat-Wilson Syndrome, clinical features of Patient 1 at age: 
(A) 1 year and 6 months; (B-C) 5 years; (D-E) 13 years and 8 
months; (F-G) 18 years.Page 3 of 12
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ure.
Information regarding pubertal development in subjects
with MWS is, at the moment, limited.
Neurologic findings and behavior
MWS patients have at least moderate but usually severe
mental retardation. Hypotonia is frequent in the first
years of life; it was present in 45 out of 48 of the published
cases (93%) with available information. Developmental
milestones such as sitting and walking are very delayed
(mean age of sitting without support is 20 months, and
mean age of walking is 4 years and 3 months (range: 23
months to eight years), though some remain non-ambu-
latory [5,9-12,18,19]. Some patients were noted to have a
wide-based or ataxic-like gait, sometimes they held their
arms up and flexed at the elbow, reminiscent of individu-
als with Angelman syndrome [9,19]. Fine motor skills are
delayed. The oldest individuals (aged over 20 years) are
able to drink from a cup, but need assistance with dressing
and activities of daily living [19].
Speech is typically limited to a few words, with onset at
around 5–6 years. Some patients do not speak at all. How-
ever, reports in the genetic literature, along with anecdotal
reports from families and educators, suggest that many
patients have receptive language skills and communicate
successfully using alternative methods, like sign language
[9,10,19].
Most subjects have a happy demeanour with frequent
smiling and a happy, affectionate, and sociable personal-
ity [9,11,12,19]. Some patients have stereotypes with
repeated movements of hands and head, other children
are fascinated by turning the pages of books and maga-
zines [19].
Seizures or abnormal electroencephalogram (EEG) are
described in 102 out of 139 of the published cases (73%)
[19,22,24,29-31], although no particular seizure type is
characteristic of the condition. The seizures are variable in
nature, from absences to generalized seizures and myo-
clonic seizures [9,19]. Onset of seizures usually occurs in
the second year of life, but seizures may begin in the neo-
natal period, in infancy or in late childhood, or at over ten
years of age [9,10,19]. In some cases, the seizures are
resistant to treatment in childhood, but appear to be more
easily managed in adolescents and adults [9].
Main common features of the patients with Mowat-Wilson Syndrome: upli ted ear l bes as "orecchiette past " or "red blood corp scles"Figu e 4
Main common features of the patients with Mowat-Wilson 
Syndrome: uplifted ear lobes as "orecchiette pasta" or "red 
blood corpuscles".
Mowat-Wilson Syndrome, clinical features of Patients 3 and 4 at age: Patients 3: (A) 1 y ar a d 2 month ; (B) 3 years and  m nths; (C) 8 years and 1 month; P ient  4: (D) 3 years; (E)3 years; (F) 3 years and 6 mo thsFigu e 3
Mowat-Wilson Syndrome, clinical features of Patients 3 and 4 
at age: Patients 3: (A) 1 year and 2 months; (B) 3 years and 4 
months; (C) 8 years and 1 month; Patients 4: (D) 3 years; (E) 
3 years; (F) 3 years and 6 months.Page 4 of 12
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agenesis of corpus callosum, which was present in 67 out
of 155 of the published cases (43%) [19,22,24,29-31],
ventriculomegaly [19], cortical atrophy [6,20,25], pachy-
gyria and cerebellar hypoplasia [30,31], poor hippocam-
pal formation [13] and frontotemporal hypoplasia with
temporal dysplasia [3,9]. These findings may be under-
represented because not all published cases underwent
cranial imaging.
Hirschsprung disease
Hirschsprung disease was present in 97 out of 170 of the
published cases (57%) [19,22,24,29,31].
Many patients without known HSCR have been noted to
have severe constipation, not investigated by rectal
biopsy. Constipation was in fact present in 19 out of 73 of
the published cases without HSCR (26%) [19,22,29]. A
milder form of HSCR might not be diagnosed in infancy.
The data on the length of the aganglionic segment is
incomplete in published cases, but short and long seg-
ments are both reported in males and females. Patients
with ZEB2 deletion, but not those with mutations, tend to
develop aganglionosis affecting longer segments [32].
This variety in the severity of HSCR in MWS may be
caused by both variations in ZEB2 abnormalities and epi-
genetic factors [32].
It is probable that MWS is under-diagnosed in patients
without HSCR and it has been well documented that this
feature is not always present [4,5,7-12,19,22,24,25]. In
the largest series of 57 cases, the frequency of HSCR was
46%, suggesting that with increasing clinical experience
the diagnosis can be made with and without HSCR [22].
Other oropharyngeal and gastrointestinal findings
Other gastrointestinal anomalies, such as pyloric stenosis
(one in case with a family history of pyloric stenosis) have
been reported in eight patients [2,7,9,10,19,22,25]. A
highly arched palate is often present, possibly secondary
to hypotonia [9]. Submucous cleft, cleft soft palate, cleft
hard palate, and bilateral cleft lip and palate have been
described by some authors [1,3,9,10,20,22,25]. A patient
with velopharyngeal insufficiency with laryngomalacia,
glossoptosis and micrognathia, as opposed to a promi-
nent chin has been described [19]. This patient had a large
deletion encompassing the ZEB2 gene, and therefore, it is
unclear whether these additional findings may be related
to haploinsufficiency of genes surrounding the ZEB2
locus [19].
Congenital heart disease
Congenital heart disease was demonstrated in 87 out of
167 (52%) of the published cases [19,22,24,29-31].
The wide spectrum of heart defects observed include pat-
ent ductus arteriosus (16 patients), pulmonary stenosis
(12 patients) and ventricular septal defect (12 patients),
which are the most common, atrial septal defect (8
patients), pulmonary artery sling (6 patients), Tetralogy of
Fallot (5 patients), pulmonary atresia (1 patient), periph-
eral pulmonary artery stenosis (1 patient), missing pul-
monary artery (1 patient), aortic coarctation (4 patients),
bicuspid aortic valve (1 patient), interrupted aortic arch (1
patient), mitral prolapse (1 patient) and aortic valve sten-
osis (1 patient) [1,5,7-14,17-19,22,25].
Structural heart defects are variable, but seem to fre-
quently involve the pulmonary arteries and/or valves.
Five patients have been reported with a rare, unusual con-
genital heart disease, pulmonary artery sling, two of
whom also had tracheal stenosis/hypoplasia [18,19,25].
Another patient had tracheal stenosis with aortic valvular
stenosis [22]. In 2007, Dastot-Le Moal suggested that pul-
monary artery sling with or without tracheal stenosis may
be a particular association of MWS and should prompt the
clinician to consider this diagnosis [22].
Main common features of the patients with Mowat-Wilson Syndrome: large eyebrows, medially flaring and sparse in the mid le partFigu e 5
Main common features of the patients with Mowat-Wilson 
Syndrome: large eyebrows, medially flaring and sparse in the 
middle part.Page 5 of 12
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Urogenital/renal anomalies were demonstrated in 81 out
of 156 of the published cases (51%) [19,22,24,29-31].
In 63 out of 100 males with MWS for whom this informa-
tion was available, 58 had genital anomalies, and hypos-
padias was present in 33/63 patients (52%). This
frequency is high for a single anomaly within a multiple
congenital anomalies/mental retardation syndrome,
where clinical signs can be variably present. From the
analysis of EUROCAT data, hypospadias affects about 3
per 1000 male births [33]. Cryptorchidism was described
in 36% of patients (23/63), bifid scrotum and webbed
penis were identified in 3 out of 63 cases, and micro-phal-
lus in 1 patient. Eight out of 63 males with genitalia
anomalies, have both hypospadias and cryptorchidism
[5,7,9,12,16-20,24,25,32]. Only one female with MWS
had genital anomalies, consisting of a vaginal septum
[25].
Other genitourinary anomalies in children with MWS
included duplex kidney (1 patient) [1], pelvic kidney (1
patient) [9], vesicoureteric reflux (10 patients)
[7,9,10,13,19,22,24] and hydronephrosis (8 patients)
[7,10,12,13,18,19].
Musculoskeletal
Musculoskeletal anomalies occur in many patients. Most
individuals are of slender build. In childhood they are
described as having slender and tapering fingers, some-
times with prominent fingertip pads, with prominence of
the interphalangeal joints developing in later childhood,
adolescence and adulthood [9,12,19,34]. The feet have
been described as having pes planus, mild calcaneovalgus
deformity and long toes [9,12,19,34]. The following fea-
tures have been reported in at least one affected subject:
wormian bones, pectus excavatum, pectus carinatum,
superior pectus carinatum/inferior pectus excavatum, sco-
liosis, genu valgus, recurrent non-traumatic patellar dislo-
cation, mild contractures of the hip, elbows and knees,
ulnar deviation of the hands, radial deviation of the
thumbs, short broad thumbs, proximally placed thumbs,
adducted thumbs (positional), 1st–2nd finger syndactyly,
distal phalanges of fingers hypoplasia, camptodactyly,
delayed bone age, broad halluces, long halluces, hallux
valgus, unilateral duplication of the hallux, hypoplasia of
halluces, hypertrophic first ray of the feet, middle and dis-
tal phalanges hypoplasia of toes, brachytelephalangia,
overriding of the 2nd toe over the 1st and 3rd toes [1-3,6,9-
11,16,19,20,22,34].
Eye defects
Eye structural anomalies have only recently been reported
in association with MWS and were described in 7 out of
170 of the published cases (4,1%) [18,22]; three had
microphthalmia (one of whom with in addition iris colo-
boma and cataract), three h ad iris/retinal/optic disc colo-
bomas, and one Axenfeld anomaly [17-19,22,28,34]. One
patient with coloboma and high myopia had a novel
ZEB2 missense mutation and trisomy 21 [28]. These eye
findings are consistent with the expression of the gene in
the developing eye [18].
Strabismus, although quite rarely mentioned, was also
evident in many photographs and appears to be frequent.
Nystagmus due to fixation difficulties is frequently
described in infancy, but tends to resolve with age [9,34].
The following features have been reported in at least one
affected subject: ptosis, myopia, astigmatism, dark pig-
ment clumps in blue irises, described as irides heterochro-
mia by some authors [9,12,34].
A pediatric ophthalmologic evaluation should therefore
be performed in any individual with MWS.
Hearing function
Recurrent episodes of otitis media have been described in
patients with MWS. Hearing loss was not found in
patients tested, although children with recurrent or
chronic otitis media are at risk of conductive hearing loss
[9,19,34]. An audiological evaluation should be per-
formed in all children with language impairment, includ-
ing MWS patients [19,34].
Teeth anomalies
There is limited available information regarding the den-
tal characteristics of patients with MWS. The following
features have been reported in at least one affected sub-
ject: widely spaced teeth, dental crowding, "malposi-
tioned" teeth, delayed tooth eruption [19,34].
Skin
One patient with MWS has been described as having grad-
ual onset of widespread "raindrop" depigmentation on
the trunk [9,10]. Depigmentation was otherwise reported
in two other subjects [3,22]. Dermatoglyphic anomalies/
deep palmar and plantar creases have been described in at
least eight patients [6,12]. Three subjects have been found
to have accessory nipples [19]. Preauricular tag was
reported in one individual [1].
Other clinical features
One patient with MWS had asplenia [18]. Another one
had autonomic dysregulation (later onset) [3,22].
Repeated vomiting attacks, suggestive of epilepsy, were
observed in five cases [25].Page 6 of 12
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MWS is caused by an heterozygous mutation in the ZEB2
gene (OMIM# 605802) [35] that was identified by Waka-
matsu et al and Cacheux et al in 2001 [2,3]. Mowat et al
described the syndrome in 1998 and also identified a
locus at chromosome 2q21-q23 [1].
The ZEB2 gene spans approximately 70 Kb, consists of 10
exons and 9 introns (Figure 6), and encodes for SIP1
(Smad interacting protein 1, SMADIP1) [2]. The initiation
codon is located in exon 2 and the stop codon is in exon
10. SIP1 is a zinc finger/homeodomain transcriptional
repressor and consists of 1214 amino acids [36-39]; ZEB2
mRNA is detected in nearly all human tissues [3,8,40,41].
Clinical features suggest that the ZEB2 gene is involved in
the development of neural-crest derived cells (enteric
nervous system, craniofacial mesectoderm), central nerv-
ous system, heart septation (patent ductus arteriosus, ven-
tricular and atrial septal defect) and midline development
(corpus callosum agenesis, genitourinary anomalies and
pyloric stenosis) [5,7,25]. Comparison of the human and
mouse homologues of ZEB2 at the nucleotide and amino
acid levels revealed 93% and 97% similarities, respec-
tively [2,3].
To date, 171 patients have been published [4,9-
12,18,19,22,24,29-31]. In all of these patients, hetero-
zygous mutations of the zinc finger E-box-binding home-
obox 2 gene (ZEB2) were detected. In most cases the
mutation produces an absent or truncating protein [9]
which loses its function.
The most frequent mutations are: frameshift mutations
(small insertions and deletions that lead to truncating
frameshift mutations) (41,5%) [2,3,5-8,10,17-
19,22,23,25], non-sense mutations (31,6%)
[2,5,7,8,10,12,18,22,24,25], and deletions (not detecta-
ble by standard cytogenetic method) (19,3%)
[2,7,11,18,19,22,24,25,29,31]. Rare mutations have been
reported: cytogenetically detectable deletions (1,2%)
[1,14], translocation (0,6%) disrupting the disease-gene
[3], splice site mutations (2,3%) [10,18,21], missense
mutations (1,7%) [20,22,28], complex mutations (com-
bination of deletion and insertion) (1,2%) [22,25] and an
inframe mutation (0,6%) [27].
The mutations cover all the coding region [9], and are
more frequent in exon 8 (69 cases, 51,1%) [22]. Four
recurrent mutations have been observed: 2083C > T (13,
exon 8), 2761C > T (5, exon 8) 1027C > T (4, exon 8) and
904C > T (3, exon 7) [8,18,22].
Scheme of ZEB2 exons and corresponding protein structure adapted from Zweier et al [4], showing the position of the pre-sented mutationsFigure 6
Scheme of ZEB2 exons and corresponding protein structure adapted from Zweier et al [4], showing the position of the pre-
sented mutations. NZF, N-terminal zinc finger cluster; CZF, C-terminal zinc finger cluster; SBD, Smad binding domain; HD, 
homeodomain like segment. [5, 11, 15, 17, 28].Page 7 of 12
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to have the same severe phenotype that those found in
patients with large 2q22 deletions, it has been pointed out
that MWS is not a contiguous gene syndrome, and that
truncating mutations of one allele of the ZEB2 gene are
sufficient to result in this complex phenotype [12].
Haploinsufficiency is probably the underlying mecha-
nism [7-11,18,22,42].
Few studies on polymorphisms have been carried out. The
amino acid altering change p.Pro714Leu, localized in
exon 8, was found in one patient (in addition to a non-
sense mutation) and in his healthy father, but was not
detected in 96 normal controls [18].
The silent alteration p.Ile163Ile was identified both in one
patient and in his father [18]. The small number of poly-
morphisms indicates that ZEB2 sequence is under strong
evolutionary constraint and even small variations com-
promise the protein function [18]. A recent study on pol-
ymorphisms by Dastot et al, 2007, in 180 children (120
unaffected and 60 MWS patients) showed 20% polymor-
phism in exon 7 (transition T4C in intron 7 (c.917-
21T4C) in both groups. The authors identified an amino
acid change in exon 10 (amino acid change
p.Glu1094Lys) in a typical patient who also had a total
deletion of ZEB2 on the other chromosome. As this alter-
ation was also identified in the healthy mother, it was
probably a polymorphism [22].
In two cases of typical MWS, the mutation was not identi-
fied [10]. It could be due to the presence of mutations not
detectable by mutational screening, or it could also indi-
cate genetic heterogeneity for this clinical syndrome [10].
Genotype-phenotype correlation
The studies on genotype-phenotype analysis show that in
most cases the phenotype was similar in patients with
deletions and in those with truncating mutations
[11,12,18]. Patients with large deletions may have a more
severe phenotype and additional features [11,25,30,31].
Facial gestalt and the psychomotor development delay,
particularly of language, are constant. The frequent and
severe malformations (HSCR, congenital heart defect,
agenesis of the corpus callosum) and seizures may lead to
suspicion of the diagnosis, but their presence is variable
[5,9,12,17,18,22].
The comparison between clinical data concerning the
associated malformations of one of the patients with a
R695X mutation and those of the other eight patients with
the same mutation, demonstrated the phenotypic varia-
bility of a single mutation in MWS [4,12]. This variability
is remarkable not only in the same mutation but also in
the same family. In fact, two siblings (sister and brother)
with characteristic face, HSCR and agenesis of the corpus
callosum were discordant for congenital heart disease and
ocular coloboma [17]. On the other hand, the phenotypic
expression in two affected sisters was very similar for a/
hypoplasia of corpus callosum, HSCR, congenital heart
defect, seizures and microcephaly [18]. These features
might be controlled by common familial genetic modifi-
ers [18].
Few data are available about the parental origin of dele-
tions. The origin of the deleted chromosome is paternal in
17 out of 19 patients examined so far [11,22,25,42]. The
investigation of four patients showed that agenesis of cor-
pus callosum (present in two patients and absent in two
others) and seizures (present in one patient and absent in
three others) showed no correlation with paternal origin
of the deletion [11].
HSCR, when present, is a strong cross reference marker,
even in the neonatal period, but it is not constant. It is
noteworthy that at first the patients were selected among
those with syndromic HSCR. As the number of described
patients with ZEB2 mutations rises, the percentage of
patients with HSCR decreases: 70% of 30 patients [11],
62% of 45 [9], 63.8% of 47 [12], 62.8% of 70 [4], 62,6%
of 97 [18], 57.2% of 159 [22] and 57% of 170. Therefore,
there was a bias of ascertainment.
Also the male preponderance of HSCR in general popula-
tions (4:1) [43] can cause a bias of ascertainment and
explain the male excess in MWS [9]. In fact, the male/
female ratio decreases from 2.13/1 out of 47 patients (M/
F 32/15) [12] to 1.92/1 out of 70 patients (M/F 46/24)
[4], to 1.49/1 out of 97 patients (M/F 58/39) (personal
data), to 1.37/1 out of 159 patients (M/F 92/67) [22] and
today 1.42/1 out of 170 patients (M/F 100/70).
The manifestation of HSCR is not influenced by deletion
size [11]. Moreover, Zfhx1b knockout mice do not exhibit
HSCR [44], therefore a non-allelic modifier might con-
tribute to the manifestation of HSCR [11].
Unusual mutations can lead to an atypical phenotype.
The first person reported was a 48-year-old woman with
severe constipation and mild mental retardation in the
absence of specific facial anomalies, seizures, and other
malformations caused by non-truncating mutations with
a 3 bp in frame deletion [27].
Three patients with ZEB2 missense mutations showed a
clinical severity as variable as expected. The first was a boy
with Down syndrome and typical facial features of tri-
somy 21, HSCR (rarer in Down syndrome than in MWS),
myopia, and ocular coloboma affecting iris and retinaPage 8 of 12
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with MWS but not the facial gestalt. The importance of
ocular anomalies that differs and are more severe than
those observed in Down syndrome is underlined.
Another boy with a missense mutation [20] showed
HSCR, corpus callosum hypoplasia, epilepsy and severe
mental retardation, but also other anomalies such as cleft
lip and palate, brachytelephalangy, and broad thumbs
and halluces. Facial phenotype was similar to MWS but
differed by the presence of bilateral cleft lip and palate,
and eyebrows that were not typical of MWS.
The third missense mutation was found in a young child
with typical MWS including HSCR who died at age of 3
years [22].
An exceptionally mild phenotype, caused by a novel and
unusual splice site mutation in the 5'UTR, was reported by
Zweier et al (2006) in a 5-year-old child. He showed a
mild motor and speech delay but, by age 5 years, he spoke
in full sentences. The phenotype was not typical but facial
features resembled the facial gestalt of MWS. Clinical fea-
tures were mild in comparison with these associated with
truncating mutations, no malformations or seizures were
present. The mild phenotype could be due to the conser-
vation of all known functional domains of the protein: in
fact, this mutation only results in loss of exon 2 [21]. The
authors suggested that exon 2 might contain important
determinants of the facial phenotype in MWS [21]. Three
other splice site mutations [10,18] have been identified in
patients with typical phenotypes.
The confirmation of the diagnosis based on the presence
of a mutation, deletion or translocation in the ZEB2 gene
will allow the knowledge on genotype-phenotype correla-
tion to be increased.
Diagnostic methods
Diagnosis may be suspected on the basis of the clinical
phenotype in typical patients. Facial gestalt is particularly
important. Serious malformations (HSCR, heart disease,
agenesis of corpus callosum) are common even if not
always present. Seizures are frequent and psychomotor
delay, particularly serious in spoken language, is constant.
A small number of patients with rare mutations (inframe,
missense and splice site mutations) may show an atypical
clinical picture (until now, 2.4% of the patients: 4/169).
In all cases, patient should undergo molecular analysis of
the ZEB2 gene.
A cytogenetic analysis should be carried out to exclude
large deletions or translocations. FISH analysis enables
submicroscopic deletions to be detected. Sequencing of
the complete coding sequence of ZEB2 identifies the
mutations [5,9,22]. The semi-quantitative fluorescent
multiplex polymerase chain reaction (PCR) assay allows
detection of other rearrangements that escaped conven-
tional methods [22]. Sequence analysis detects mutations
in approximately 79% of affected individuals, FISH anal-
ysis detects deletions in 13%, chromosomal rearrange-
ments cause MWS in 2% and an additional 6% have an
intermediate-sized deletion detected by quantitative PCR
or multiplex ligation-dependent probe amplification
(MLPA) [34].
In a patient with multiple congenital anomalies and an
apparently balanced translocation involving chromo-
somes 2, 3 and 5, 1 Mb resolution array-CGH detected a
cryptic deletion of about 6 Mb of chromosome 2 includ-
ing the ZEB2 gene [29]. The patient, a six-month-old girl,
had dysmorphic features typical of MWS, microcephaly
and severe psychomotor retardation.
Differential diagnosis
The facial features of patients with MWS are quite charac-
teristic, but the presence of HSCR, epilepsy and mental
retardation may initially suggest Goldberg-Shprintzen
syndrome (GOSHS) [5]. The patients with GOSHS (actu-
ally MIM 609460) share clinical features such as HSCR,
epilepsy and mental retardation, but have a different
facial gestalt (high nasal bridge, synophrys, long curled
eyelashes, palpebral ptosis, and cleft palate are commonly
observed) [45,46]. The differential diagnosis can be car-
ried out on the basis of facial phenotype and confirmed
by mutational analysis of the ZEB2 gene. A patient with
short segment HSCR, microcephaly, mental retardation,
and distinct facial appearance in the absence of ZEB2
intragenic mutations was diagnosed as GOSHS [30]. Fur-
ther molecular studies showed a deletion of the 2q22-q23
region encompassing the ZEB2 gene [31].
In five patients with GOSHS in a consanguineous Moroc-
can family, Brooks et al identified a homozygous muta-
tion in K1AA1279 at 10q22.1 [47]. Today, it is possible to
carry out molecular analyses for both syndromes.
The differential diagnosis is important for genetic coun-
seling, since GOSHS is autosomal recessive, whereas MWS
is a sporadic condition.
ZEB2 mutation analysis may be also considered in
patients with syndromic [43] and apparently non-syndro-
mic HSCR disease and no mutation in other related genes
such as RET or EDNRB [20,48,49].
Individuals with MWS have often been described as hav-
ing a wide-based or ataxic-like gait, and a smiling, happy
and sociable personality. This, combined with absent
speech, microcephaly and seizures, has led some individ-Page 9 of 12
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drome [19]. However, the facial features of MWS, in
addition to the other typical congenital anomalies, distin-
guish these two conditions.
In patients with hypospadias and mental retardation it is
necessary to take into account the differential diagnosis
with Smith-Lemli-Opitz syndrome, Opitz G/BBB syn-
drome and X-linked mental retardation-alpha tha-
lassemia syndrome. However, the gestalt of MWS is
different.
Genetic counseling
The majority of patients with MWS so far reported are spo-
radic cases; therefore the recurrence risk is low. Neverthe-
less, cases of sibling recurrence have been observed.
Two sisters with MWS born to healthy parents have been
reported. Mutation analysis of both parents revealed a low
paternal mosaicism. The father had short stature (150 cm,
Vietnamese origin), somewhat uplifted earlobes and a
pointed nasal tip [18].
Another recurrence was found in a brother and a sister
with clinical features of MWS and the same truncating
mutation in exon 8. The parents were phenotypically nor-
mal, without mutation in the ZEB2 gene. Thus, the most
likely explanation is germ-line mosaicism [17].
Recently, another family with three affected sibs has been
reported [[34] by D. Mowat, personal communication].
Therefore, the recurrence risk, on the basis of the current
data, is 3/170 families (1.76%) [17,18,34].
In the case of a balanced familial translocation, the risk is
higher. Karyotype and gene analysis should be offered to
the parents with an affected child and, in these cases, pre-
natal diagnosis is possible.
Antenatal diagnosis
There are few data concerning specific prenatal markers
suitable during pregnancy. Wilson et al (2003) reported
increased nuchal translucency in two patients [10].
Since agenesis of the corpus callosum is the only MWS fea-
ture that can be detected prenatally, molecular screening
of the ZEB2 gene in prenatal isolated agenesis of the cor-
pus callosum, has been carried out [50]. No gene muta-
tions were detected in six fetuses. It has been concluded
that ZEB2 is not the major gene for isolated agenesis of the
corpus callosum and that a particular attention to the
facial features (dysplastic ears) at ultrasound or fetopatho-
logical examination may help the diagnosis of MWS in
fetuses with agenesis of the corpus callosum.
Only one case of examinations in pregnancy has been per-
formed in a family with two children affected by MWS
[17]. The first child, a female, had HSCR, dysmorphic fea-
tures and developmental delay. The cerebral magnetic res-
onance imaging (MRI) showed agenesis of the corpus
callosum but the karyotype analysis was normal; thus,
diagnosis was not made. On the second pregnancy, a
nuchal translucency scan was reported as normal, but
both fetal ultrasound and MRI examination showed agen-
esis of the corpus callosum. Amniocentesis demonstrated
a normal male karyotype [17]. MRI examination of the
mother showed a normal corpus callosum. It could be
supposed that the absence of diagnosis on the first child
did not allow a correlation of agenesis of corpus callosum
with the recurrence of a syndrome.
Other observations and studies are necessary to increase
the knowledge and identify possible prenatal markers.
Management
There is no specific treatment for MWS, as the neural
defect and also other malformations resulting from the
mutation occur in the early stage of embryonal develop-
ment [41].
The frequent presence of serious congenital malforma-
tions requires precocious clinical investigation with inter-
vention of neonatologists, pediatricians and several
specialists. Congenital heart disease and HSCR requires
early surgery at the first days or months of life. Serious
constipation also persists in operated patients.
Seizures can begin in the first months of life and require
suitable therapies; however, in two of our patients the sei-
zures were fairly quickly resolved. One patient still has sei-
zures at the age of 9 years, while the other, at the age of six,
had never suffered them.
Genitourinary anomalies such as hypospadias, cryp-
torchidism, bifid scrotum, vesicoureteral reflux and
hydronephrosis may be present in the first years of life
and may require surgery.
Eye problems are frequent and require a specialized help.
Deafness has not been reported. Nevertheless, speech
retardation requires audiometric examination of all MWS
children.
All advised vaccinations are recommended.
A periodic follow-up for the different clinical problems
should be carried out regularly.Page 10 of 12
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therefore rehabilitation including physical therapy, psy-
chomotor and speech therapy should be started as soon as
possible.
Prognosis
There are few data about survival of the patients affected
by MWS. We are aware of the death of three patients. One
patient with a large deletion and seizures in the neonatal
period [11], and a patient with aortic valvular stenosis
[22] both died in the first month of life. The third patient,
having a missense mutation, died at 3 years of age [22].
As far as we know, the oldest patient reported so far is 30-
years-old [25].
Early molecular diagnosis is feasible today and is of great
importance in order to start the therapeutic and rehabili-
tation treatment as soon as possible.
The diagnosis of MWS is important also for the family,
regardless of the prognosis. In fact, the diagnosis permits
caregivers to give information and psychological support,
and relieves the families from a profound sensation of sol-
itude.
The increase of knowledge on the syndrome will support
the educational and rehabilitation aid by parents and car-
egivers, and help the achievement of improvements in the
psychomotor development and the autonomy of the
MWS patients.
The support resulting from Family Associations is also
important.
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